The first unified platform for comprehensive cross species brain analytics
Home > LucerumKey
A multivariate, multimodal, neuroinformatics workspace
LucerumKey de-fragments, simplifies and accelerates neuroscience-focused research in a secure and collaborative ecosystem fit for life sciences, pharmaceutical, academia, clinical research, and AI developers.
Bridging Research and Therapeutic Innovation - From Discovery to Clinical Trials
- Advanced neuroanalytics for all EEG modalities
- Cross-species translational pharmaco-EEG
- Brain connectomics with pipeline automation
- Functional-molecular correlates
- Multiple neuroimaging modalities – EEGt, MEG, fNIRS and more
- Study planner and embedded statistics
- Data curation, analytics, report automation
A Flexible Workflow and User Interface Designed for Teams
- Rapidly plan and design scientific studies
- EEG curation from any system
- Pharmaco-EEG Interactive Views
- Automation of workflows and integrated statistics
- Bioinformatics-ready outputs
- Flexible interactive 2D and 3D graphics
- Easy data and graphics exports and data exchange
- Regulatory- and SEND-ready reports
Integrated Biosignals - Multimodal Neuroimaging
LucerumKey platform integrates multivariate physiological data from a range of sources: EEG/MEG, fNIRS, sleep, temperature, activity, cardiovascular, ECG, pharmacokinetics (PK), behavioral, wearables, and more.
Reduce operational overhead with automated ECG analytics for preclinical drug safety (S7A)
LucerumKey AI
In addition to embedded standard parametric and non-parametric statistics, we employ advanced Artificial Intelligence (AI) and Machine Learning (ML) models for applications in drug development and clinical research.
New Capability: Neurotransmitter Predictions
Relating Neural Oscillations to Molecular Targets
To relate neurotransmitter or transporter contribution to changes in neural oscillations due to a drug or therapeutic intervention, we use models which predict the cortical power distribution of each EEG frequency band using normative PET or autoradiography-derived neurotransmitter cortical densities, aligned with normative EEG databases. We apply dominance analyses to identify the neurotransmitters that contributed most to the fit (e.g., comparing before and after treatment). The differences between conditions highlight changes in NT dominance which provide powerful insight into the target.
LucerumKey Process
Interface Assisted Study Design
Design study and enter data with our intuitive study planner.
EEG and Signal Data Curation
The signals are curated (deartifacted, binned, marked) for next step analyses based on standard and user requirements.
Neuroanalytics and Statistics
qEEG, pharmaco-EEG, EEG/MEG/Tomography, sleep scoring, biosignal anlyses, etc. and statistics are performed and added to the database
2D and 3D Interactive Visualization of Results
Switch between group statistics and subject results, create custom graphs, and visualize 3D brain-maps interactively.
AI & Machine Learning-Ready Data
Explore the high-dimensional therapeutic feature space. Alternately, export the data for your neuroinformatics team.
Reporting
Automated reports are generated with standard or customer specific templates. IND-ready reports with interpretation by experts and consultation are available.
Defragmenting Data and Processes in Pharma and Life Sciences
Evolving Solutions
Science and organizational imperatives evolve rapidly. LucerumKey evolves with your needs based on scalable storage and computing infrastructure. Standardization, AI-readiness, and flexibility in adding data dimensions accelerates and future-proofs your research.
How can LucerumKey help me?
-
You are in the pharma, academic, clinical, or biotech space, but lack infrastructure for CNS functional data. You need a robust, scalable analytical database solution for your business or research.
You are a CRO offering electrophysiology services, struggling to streamline operations, cut costs, and gain a competitive edge.
You need electrophysiology or neuroimaging endpoints for preclinical or clinical projects but don’t know where to start.
You have historical pharmaco-EEG, electrophysiology (cardiovascular, toxicology, behavioral, etc.), or neuroimaging data from multiple systems. De-siloing and creating an AI-ready database feels overwhelming.
You rely on too many experts (data analysts, neuroscientists, statisticians, etc.), and software (Matlab, etc.) making it hard to generate actionable data quickly and affordably.
Your scientific team’s work is fragmented, with no platform to unify data and facilitate seamless communication and sharing.
You want to form a consortium to unify functional CNS data sharing and analytics but lack the tools to make it happen.
Your clinical trial requires functional brain analytics or responder stratification based on quantitative EEG and multivariate data. A unified solution for collection and analysis is essential.
You are an academic researcher with a hypothesis and study plan, but need advanced support for EEG/MEG/fMRI/fNIRS analytics and/or statistical modeling.
You are a clinical researcher, exploring biomarkers for disease or treatment response but lack AI/ML capabilities or advanced connectome and brain mapping tools.
You are an AI or neurotech developer, seeking to generate neuroanalytics and connect with expert networks to advance your projects.
You are a neuromodulation clinician, needing qEEG guidance for E-field localization, biofeedback, and efficacy endpoint follow-up.
You are a consumer interested in brain biometrics and optimization.